Journal Article
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C.,
“Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”,
J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
Y. Ying Lim, Pase, M. P., Buckley, R. F., Yassi, N., Bransby, L., Fowler, C., Laws, S. M., Masters, C. L., and Maruff, P.,
“Visual Memory Deficits in Middle-Aged APOEɛ4 Homozygotes Detected Using Unsupervised Cognitive Assessments.”,
J Alzheimers Dis, vol. 79, no. 4, pp. 1563-1573, 2021.
T. Porter, Burnham, S. C., Milicic, L., Savage, G., Maruff, P., Lim, Y. Ying, Li, Q. - X., Ames, D., Masters, C. L., Rainey-Smith, S., Rowe, C. C., Salvado, O., Groth, D., Verdile, G., Villemagne, V. L., and Laws, S. M.,
“Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 1193-1211, 2018.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C.,
“Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”,
J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
B. M. Brown, Rainey-Smith, S. R., Doré, V., Peiffer, J. J., Burnham, S. C., Laws, S. M., Taddei, K., Ames, D., Masters, C. L., Rowe, C. C., Martins, R. N., and Villemagne, V. L.,
“Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.”,
J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
B. R. Cardoso, Hare, D. J., Bush, A. I., Li, Q. - X., Fowler, C. J., Masters, C. L., Martins, R. N., Ganio, K., Lothian, A., Mukherjee, S., Kapp, E. A., and Roberts, B. R.,
“Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL).”,
J Alzheimers Dis, vol. 57, no. 1, pp. 183-193, 2017.
S. Hani Mouss Nik, Porter, T., Newman, M., Bartlett, B., Khan, I., Sabale, M., Eccles, M., Woodfield, A., Groth, D., Doré, V., Villemagne, V. L., Masters, C. L., Martins, R. N., Laws, S. M., Lardelli, M., and Verdile, G.,
“Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.”,
J Alzheimers Dis, vol. 80, no. 4, pp. 1479-1489, 2021.
C. Dang, Harrington, K. D., Lim, Y. Ying, Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., Sohrabi, H. R., Salvado, O., Weinborn, M., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P.,
“Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults.”,
J Alzheimers Dis, vol. 65, no. 4, pp. 1313-1325, 2018.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N.,
“Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.”,
J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L.,
“Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease.”,
J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
K. E. Peters, Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., and Bruce, D. G.,
“Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1127-1133, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A.,
“A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
S. L. Gardener, Weinborn, M., Sohrabi, H. R., Doecke, J. D., Bourgeat, P., Rainey-Smith, S. R., Shen, K. - K., Fripp, J., Taddei, K., Maruff, P., Salvado, O., Savage, G., Ames, D., Masters, C. L., Rowe, C. C., and Martins, R. N.,
“Longitudinal Trajectories in Cortical Thickness and Volume Atrophy: Superior Cognitive Performance Does Not Protect Against Brain Atrophy in Older Adults.”,
J Alzheimers Dis, vol. 81, no. 3, pp. 1039-1052, 2021.
N. Yassi, Hilal, S., Xia, Y., Lim, Y. Ying, Watson, R., Kuijf, H., Fowler, C., Yates, P., Maruff, P., Martins, R., Ames, D., Chen, C., Rowe, C., Villemagne, V., Salvado, O., Desmond, P. M., and Masters, C. L.,
“Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease.”,
J Alzheimers Dis, vol. 73, no. 3, pp. 897-907, 2020.
S. L. Gardener, Rainey-Smith, S. R., Sohrabi, H. R., Weinborn, M., Verdile, G., Fernando, W. M. A. D. Bino, Lim, Y. Ying, Harrington, K., Burnham, S., Taddei, K., Masters, C. L., Macaulay, S. L., Rowe, C. C., Ames, D., Maruff, P., and Martins, R. N.,
“Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.”,
J Alzheimers Dis, vol. 58, no. 1, pp. 193-201, 2017.
M. N. Sabbagh, Schäuble, B., Anand, K., Richards, D., Murayama, S., Akatsu, H., Takao, M., Rowe, C. C., Masters, C. L., Barthel, H., Gertz, H. - J., Peters, O., Rasgon, N., Jovalekic, A., Sabri, O., Schulz-Schaeffer, W. J., and Seibyl, J.,
“Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 2, pp. 441-446, 2017.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A.,
“Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”,
J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
J. E. Baker, Lim, Y. Ying, Jaeger, J., Ames, D., Lautenschlager, N. T., Robertson, J., Pietrzak, R. H., Snyder, P. J., Villemagne, V. L., Rowe, C. C., Masters, C. L., and Maruff, P.,
“Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.”,
J Alzheimers Dis, vol. 65, no. 3, pp. 977-988, 2018.
Y. Ying Lim, Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., Rainey-Smith, S., Salvado, O., Martins, R. N., Rowe, C. C., Masters, C. L., and Maruff, P.,
“Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.”,
J Alzheimers Dis, vol. 58, no. 4, pp. 1293-1302, 2017.
M. Waller, Buckley, R. F., Masters, C. L., Nona, F. R., Eades, S., and Dobson, A. J.,
“Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”,
J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
J. D. Doecke, Rembach, A., Villemagne, V. L., Varghese, S., Rainey-Smith, S., Sarros, S., Evered, L. A., Fowler, C. J., Pertile, K. K., Rumble, R. L., Trounson, B., Taddei, K., Laws, S. M., S Macaulay, L., Bush, A. I., Ellis, K. A., Martins, R., Ames, D., Silbert, B., Vanderstichele, H., Masters, C. L., Darby, D. G., Li, Q. - X., and Collins, S.,
“Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.”,
J Alzheimers Dis, vol. 61, no. 1, pp. 169-183, 2018.
Y. Xia, Yassi, N., Raniga, P., Bourgeat, P., Desmond, P., Doecke, J., Ames, D., Laws, S. M., Fowler, C., Rainey-Smith, S. R., Martins, R., Maruff, P., Villemagne, V. L., Masters, C. L., Rowe, C. C., Fripp, J., and Salvado, O.,
“Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.”,
J Alzheimers Dis, vol. 78, no. 1, pp. 321-334, 2020.
W. R. Leifert, Nguyen, T., Rembach, A., Martins, R., Rainey-Smith, S., Masters, C. L., Ames, D., Rowe, C. C., S Macaulay, L., François, M., and Fenech, M. F.,
“Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.”,
J Alzheimers Dis, vol. 48, no. 2, pp. 443-52, 2015.
W. M. A. D. Bino Fernando, Rainey-Smith, S. R., Gardener, S. L., Villemagne, V. L., Burnham, S. C., S Macaulay, L., Brown, B. M., Gupta, V. Bala, Sohrabi, H. R., Weinborn, M., Taddei, K., Laws, S. M., Goozee, K., Ames, D., Fowler, C., Maruff, P., Masters, C. L., Salvado, O., Rowe, C. C., and Martins, R. N.,
“Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β.”,
J Alzheimers Dis, vol. 61, no. 4, pp. 1589-1598, 2018.
S. Hollands, Lim, Y. Ying, Laws, S. M., Villemagne, V. L., Pietrzak, R. H., Harrington, K., Porter, T., Snyder, P., Ames, D., Fowler, C., Rainey-Smith, S. R., Martins, R. N., Salvado, O., Robertson, J., Rowe, C. C., Masters, C. L., and Maruff, P.,
“APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults.”,
J Alzheimers Dis, vol. 57, no. 2, 2017.
] Year 